NeuroVive Entering Chinese Market with Sihuan Alliance

LONDON – NeuroVive Pharmaceutical AB signed a deal for the development of its two lead mitochondria-sparing programs in China to add to a similar agreement in Europe that should see the two drugs through to commercialization in both markets.